HomeMAZE • NASDAQ
add
Maze Therapeutics Inc
Previous close
$12.96
Day range
$12.32 - $12.97
Year range
$11.34 - $17.00
Avg Volume
155.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Finance Magnates
39 minutes ago
Monex Takes $67M Hit from Coincheck's Nasdaq Debut Despite Crypto Boom
1.35%
0.67%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.50M | — |
Operating expense | 26.73M | 5.95% |
Net income | -24.75M | -0.02% |
Net profit margin | -990.08 | — |
Earnings per share | — | — |
EBITDA | -23.44M | 3.23% |
Effective tax rate | 1.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.61M | — |
Total assets | 192.48M | — |
Total liabilities | 93.11M | — |
Total equity | 99.37M | — |
Shares outstanding | 23.43M | — |
Price to book | -1.07 | — |
Return on assets | -29.67% | — |
Return on capital | -32.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.75M | -0.02% |
Cash from operations | -23.20M | -16.19% |
Cash from investing | -103.00K | -3,533.33% |
Cash from financing | -2.15M | -26,975.00% |
Net change in cash | -25.46M | -27.54% |
Free cash flow | -16.22M | — |
About
Founded
2017
Headquarters
Website
Employees
121
